_1777294237270_124456903.png&w=64&q=75){kind=small}
Fibroid Pharmacological Options
The article discusses the guidelines of the International Federation of Gynecology and Obstetrics regarding the treatment of uterine fibroids, which are the most common tumors of the uterus. These tumors are usually benign, and most women do not experience symptoms; however, the most common complaint is heavy menstrual bleeding and the resulting anemia. The treatment includes reducing blood loss using medications such as tranexamic acid, hormonal contraceptives, and hormonal IUDs, along with monitoring the size of the fibroid, as these medications do not shrink the tumor. To decrease the size of the fibroids and facilitate surgical procedures, drugs that suppress or mimic the hormone GnRH are used, which lead to tumor shrinkage and reduced bleeding. However, it is essential to adhere to a specified treatment duration to avoid side effects like osteoporosis. In cases where further size reduction is needed, advanced hormonal therapies are employed. These treatments are used before surgeries to make the procedures easier and to minimize bleeding.
Notice: This Is an AI-Generated Summary
Comments (0)